menu search

Agile Therapeutics Announces Preliminary Expectations for First Quarter 2023

Agile Therapeutics Announces Preliminary Expectations for First Quarter 2023
PRINCETON, N.J., April 28, 2023 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced preliminary expectations for first quarter 2023 Twirla® demand, net revenue and operating expenses. Expected First Quarter 2023 Performance Update (Unaudited) First Quarter 2023 Twirla Demand: Total demand is expected to surpass 45,000 total cycles, representing at […] The post Agile Therapeutics Announces Preliminary Expectations for First Quarter 2023 appear... Read More
Posted: Apr 28 2023, 12:01
Author Name: forextv
Views: 092034

Search within

Pages Search Results: